L879-0266 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-2-[(3,5-difluorophenyl)formamido]pentanamide

L879-0266 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-2-[(3,5-difluorophenyl)formamido]pentanamide
L879-0266 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-2-[(3,5-difluorophenyl)formamido]pentanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L879-0266
N-(1H-1,3-benzodiazol-2-yl)-2-[(3,5-difluorophenyl)formamido]pentanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L879-0266

Molecular Formula

C19H18F2N4O2 (C19 H18 F2 N4 O2)

Compound Name

N-(1H-1,3-benzodiazol-2-yl)-2-[(3,5-difluorophenyl)formamido]pentanamide

IUPAC name

N-(1H-13-benzodiazol-2-yl)-2-[(35-difluorophenyl)formamido]pentanamide

SMILES

CCCC(C(Nc1nc(cccc2)c2[nH]1)=O)NC(c1cc(F)cc(F)c1)=O

InChI

InChI=1S/C19H18F2N4O2/c1-2-5-16(22-17(26)11-8-12(20)10-13(21)9-11)18(27)25-19-23-14-6-3-4-7-15(14)24-19/h3-4,6-10,16H,2,5H2,1H3,(H,22,26)(H2,23,24,25,27)/t16-/m0/s1

InChI Key

LBECQIDQWPHYAP-INIZCTEOSA-N

MDL Number (MFCD)

MFCD27483976

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

372.37

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.817

Distribution Coefficient, logD

3.817

Water Solubility, LogSw

-3.97

Polar Surface Area

68.070

Acid Dissociation Constant (pKa)

10.35

Base Dissociation Constant (pKb)

2.74

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

21.10

L879-0266 in Drug Discovery

Included in Screening Libraries

Chelators targeting matrix metalloproteinases library (8930 compounds)

SH2 Library (10483 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Cardiovascular
  • Cancer
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases
  • Proteases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with L879-0266 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L879-0266?
Check Price and Availability of L879-0266, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L879-0266 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L879-0266
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L879-0266
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L879-0266 available by request